Skip to Main Content

Paper Details

Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO).
BMC Infect Dis
2
2023
Author NameAffiliation
Onyema OgbuaguYale University School of Medicine
Onyema OgbuaguYale University School of Medicine
Onyema OgbuaguYale University School of Medicine, 135 College Street
  • 1 - 3

Datasets

Release 1.2